Drug Profile
Pal nasal spray
Latest Information Update: 25 Aug 2006
Price :
$50
*
At a glance
- Originator Rockefeller University
- Class
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Streptococcal infections
Most Recent Events
- 25 Aug 2006 No development reported - Preclinical for Streptococcal infections in USA (Intranasal)
- 08 Feb 2002 Preclinical development for Streptococcal infections in USA (Intranasal)